COMMUNIQUÉS West-GlobeNewswire

-
Algae Biomass Organization Bringing 2019 Algae Biomass Summit to Orlando, Florida
13/12/2018 -
Diffusion Pharmaceuticals Announces 1-for-15 Reverse Stock Split As Part Of NASDAQ Compliance Plan
13/12/2018 -
Retrotope Announces First Dosing of RT001 in patients with Infantile Neuroaxonal Dystrophy (INAD)
13/12/2018 -
Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi
13/12/2018 -
Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M
13/12/2018 -
Reminder- Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease Tomorrow
13/12/2018 -
XBiotech annonce la publication de l'analyse post-hoc pour une étude sur le cancer colorectal de Phase III
13/12/2018 -
Mariner Endosurgery Wins FDA Clearance for Groundbreaking Augmented Surgical System LaparoGuard
13/12/2018 -
Sharecare launches Sharecare Rx to help make medications more affordable and convenient
13/12/2018 -
VBI Vaccines Announces Pricing of $37.5 Million Public Offering
13/12/2018 -
Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436
13/12/2018 -
Deep Blue Med Spa Announces New Profound Procedure to Treat Wrinkles and Rejuvenate Jawline
13/12/2018 -
Symphony Health Announces Availability of 340B Drug Discount Program Data
13/12/2018 -
Agritek Holdings, Inc. Applauds Passing Of 2018 US Hemp Farm Bill With Company Poised To Monetize Colorado Assets Through Approved Hemp License And Production Partners
13/12/2018 -
Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome
13/12/2018 -
Blockchain Technology Offers a Solution to Cannabis Quality Control -- CFN Media
13/12/2018 -
Yield10 Bioscience Names Sherri M. Brown, Ph.D., Former Monsanto Executive, as Special Commercial and Technical Advisor
13/12/2018 -
Aleafia Health: A New LP with 22 Medical Clinics, 50K Patients and 98,000 kg Production -- CFN Media
13/12/2018 -
NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis
13/12/2018
Pages